Alignment Healthcare, Inc. $ALHC Shares Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. increased its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 6,708.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,774,975 shares of the company’s stock after buying an additional 1,748,903 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Alignment Healthcare were worth $35,056,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Wellington Management Group LLP raised its stake in Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after acquiring an additional 6,940,277 shares in the last quarter. Invesco Ltd. grew its stake in shares of Alignment Healthcare by 122.3% in the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock worth $58,387,000 after purchasing an additional 2,294,739 shares in the last quarter. Marshall Wace LLP increased its holdings in shares of Alignment Healthcare by 173.3% during the second quarter. Marshall Wace LLP now owns 2,039,714 shares of the company’s stock valued at $28,556,000 after purchasing an additional 1,293,416 shares during the period. Voya Investment Management LLC increased its holdings in shares of Alignment Healthcare by 61.0% during the third quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company’s stock valued at $55,775,000 after purchasing an additional 1,210,930 shares during the period. Finally, Integral Health Asset Management LLC raised its stake in shares of Alignment Healthcare by 300.0% during the third quarter. Integral Health Asset Management LLC now owns 1,600,000 shares of the company’s stock valued at $27,920,000 after purchasing an additional 1,200,000 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on ALHC shares. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, March 7th. TD Cowen raised their target price on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research note on Friday, January 16th. UBS Group boosted their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 14th. JPMorgan Chase & Co. upped their price target on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, KeyCorp reiterated an “overweight” rating and issued a $28.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.56.

Alignment Healthcare Trading Up 0.9%

Alignment Healthcare stock opened at $17.58 on Thursday. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of -1,756.24, a price-to-earnings-growth ratio of 2.55 and a beta of 1.18. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The firm’s 50 day moving average price is $20.21 and its two-hundred day moving average price is $18.83.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.10. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The company’s quarterly revenue was up 44.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.16) EPS. On average, research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Insider Activity at Alignment Healthcare

In related news, insider Robert L. Scavo sold 11,285 shares of Alignment Healthcare stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total value of $201,324.40. Following the transaction, the insider owned 487,685 shares of the company’s stock, valued at approximately $8,700,300.40. This trade represents a 2.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Sebastian Burzacchi sold 15,361 shares of the business’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total value of $274,040.24. Following the sale, the chief operating officer owned 258,630 shares in the company, valued at approximately $4,613,959.20. The trade was a 5.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 2,418,393 shares of company stock valued at $46,473,667 over the last ninety days. Company insiders own 7.00% of the company’s stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.